Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 299

2.

Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge.

Fell MJ, Katner JS, Johnson BG, Khilevich A, Schkeryantz JM, Perry KW, Svensson KA.

Neuropharmacology. 2010 Mar;58(3):632-9. doi: 10.1016/j.neuropharm.2009.11.014. Epub 2009 Dec 3.

PMID:
19951716
4.

Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.

Lorrain DS, Schaffhauser H, Campbell UC, Baccei CS, Correa LD, Rowe B, Rodriguez DE, Anderson JJ, Varney MA, Pinkerton AB, Vernier JM, Bristow LJ.

Neuropsychopharmacology. 2003 Sep;28(9):1622-32. Epub 2003 Jun 25.

6.
8.

The role of NMDA receptors in regulating group II metabotropic glutamate receptor-mediated long-term depression in rat medial prefrontal cortex.

Huang CC, Hsu KS.

Neuropharmacology. 2008 Jun;54(7):1071-8. doi: 10.1016/j.neuropharm.2008.02.013. Epub 2008 Feb 29.

PMID:
18378263
9.

Attention deficit induced by blockade of N-methyl D-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: role of metabotropic glutamate receptors 2/3.

Pozzi L, Baviera M, Sacchetti G, Calcagno E, Balducci C, Invernizzi RW, Carli M.

Neuroscience. 2011 Mar 10;176:336-48. doi: 10.1016/j.neuroscience.2010.11.060. Epub 2010 Dec 28.

PMID:
21193020
10.
12.

In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).

Fell MJ, Perry KW, Falcone JF, Johnson BG, Barth VN, Rash KS, Lucaites VL, Threlkeld PG, Monn JA, McKinzie DL, Marek GJ, Svensson KA, Nelson DL.

J Pharmacol Exp Ther. 2009 Dec;331(3):1126-36. doi: 10.1124/jpet.109.160598. Epub 2009 Sep 15.

13.

Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex.

Kiritoshi T, Neugebauer V.

Neuropharmacology. 2015 Aug;95:388-94. doi: 10.1016/j.neuropharm.2015.04.003. Epub 2015 Apr 22.

14.

Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat.

Imre G, Salomons A, Jongsma M, Fokkema DS, Den Boer JA, Ter Horst GJ.

Pharmacol Biochem Behav. 2006 Jul;84(3):392-9. Epub 2006 Jul 18.

PMID:
16857251
15.

Modulation of dendritic release of dopamine by metabotropic glutamate receptors in rat substantia nigra.

Campusano JM, Abarca J, Forray MI, Gysling K, Bustos G.

Biochem Pharmacol. 2002 Apr 1;63(7):1343-52.

PMID:
11960611
16.

Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.

Okamura N, Hashimoto K, Shimizu E, Koike K, Ohgake S, Koizumi H, Kumakiri C, Komatsu N, Iyo M.

Brain Res. 2003 Nov 28;992(1):114-9.

PMID:
14604779
19.

Glucocorticoid receptors in the prefrontal cortex regulate dopamine efflux to stress via descending glutamatergic feedback to the ventral tegmental area.

Butts KA, Phillips AG.

Int J Neuropsychopharmacol. 2013 Sep;16(8):1799-807. doi: 10.1017/S1461145713000187. Epub 2013 Apr 16.

PMID:
23590841
20.

In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands.

Smolders I, Lindekens H, Clinckers R, Meurs A, O'Neill MJ, Lodge D, Ebinger G, Michotte Y.

J Neurochem. 2004 Mar;88(5):1068-77.

Supplemental Content

Support Center